StemCell2MAX ^Private

StemCell2MAX is a Portuguese biotechnology company focused on regenerative medicine. Their main goal is to address the global shortage of high-quality blood/haematopoietic stem cells (HSCs) for medical and research purposes. With a strong intellectual property position in the EU, USA, and Japan, StemCell2MAX has developed an innovative technology that promotes the survival and multiplication of scarce HSCs. In 2015, they launched a research use only (RUO) expansion product and have since achieved a growing sales track record internationally. Currently, StemCell2MAX is working towards the clinical use of their technology.